Passage Bio Inc. (NASDAQ: PASG)
$0.95
+0.0288 ( +3.13% ) 1.4M
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.95
Previous close
$0.92
Volume
1.4M
Market cap
$58.63M
Day range
$0.87 - $1.12
52 week range
$0.58 - $1.79
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Feb 13, 2024 |
| 8-k | 8K-related | 42 | Jan 05, 2024 |
| 4 | Insider transactions | 1 | Jan 03, 2024 |
| 4 | Insider transactions | 1 | Jan 03, 2024 |
| 4 | Insider transactions | 1 | Jan 03, 2024 |
| 8-k | 8K-related | 13 | Dec 29, 2023 |
| 8-k | 8K-related | 14 | Dec 20, 2023 |
| 8-k | 8K-related | 45 | Nov 13, 2023 |
| 10-q | Quarterly Reports | 64 | Nov 13, 2023 |
| 8-k | 8K-related | 12 | Sep 01, 2023 |